Evidence map›Paper›PMID 31850082›Full record

ArticleFrontiers in genetics2019

E-Cadherin Downregulation is Mediated by Promoter Methylation in Canine Prostate Cancer.

Carlos Eduardo Fonseca-Alves, Priscila Emiko Kobayashi, Antonio Fernando Leis-Filho, Patricia de Faria Lainetti, Valeria Grieco, Hellen Kuasne, Silvia Regina Rogatto, Renee Laufer-Amorim

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Carlos Eduardo Fonseca-AlvesInstitute of Health Sciences, Paulista University-UNIP, Bauru, Brazil.
Priscila Emiko KobayashiDepartment of Veterinary Clinic, School of Veterinary Medicine and Animal Science, Sao Paulo State University-UNESP, Botucatu, Brazil.
Antonio Fernando Leis-FilhoDepartment of Veterinary Clinic, School of Veterinary Medicine and Animal Science, Sao Paulo State University-UNESP, Botucatu, Brazil.
Patricia de Faria LainettiDepartment of Veterinary Surgery and Anesthesiology, School of Veterinary Medicine and Animal Science, Sao Paulo State University-UNESP, Botucatu, Brazil.
Valeria GriecoDepartment of Veterinary Medicine, Università degli studi di Milano, Milan, Italy.
Hellen KuasneInternational Center for Research (CIPE), AC Camargo Cancer Center, Sao Paulo, Brazil.
Silvia Regina RogattoDepartment of Clinical Genetics, University Hospital of Southern Denmark, Institute of Regional Health Research, University of Southern Denmark, Vejle, Denmark.
Renee Laufer-AmorimDepartment of Veterinary Surgery and Anesthesiology, School of Veterinary Medicine and Animal Science, Sao Paulo State University-UNESP, Botucatu, Brazil.
Universidade Estadual Paulista (Unesp) · BRAC Camargo Hospital · BRUniversidade Paulista · BRUniversity of Milan · ITUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

E-cadherin is a transmembrane glycoprotein responsible for cell-to-cell adhesion, and its loss has been associated with metastasis development. Although E-cadherin downregulation was previously reported in canine prostate cancer (PC), the mechanism involved in this process is unclear. It is well established that dogs, besides humans, spontaneously develop PC with high frequency; therefore, canine PC is an interesting model to study human PC. In human PC,

Indexed as

CDH1doghypermethylationprostatesurface protein

Identifiers

PMID31850082
PMCPMC6895247
OpenAlexW2990265143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.